Business
USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nUSRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nUSRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells\nAutoimmune Skin Condition Affects More Than 7 million in the United States\nPR Newswire\nSUNRISE, Fla., March 21, 2018\n\n\n\nSUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully demonstrated a 99 percent reduction in-human of the severity of psoriasis using a patient's autologous stem cells.\n\n\n \n \n\n \nThe scientific paper, which is authored by USRM Chief Science Officer Dr. Kristin Comella and her USRM colleagues, is published in the International Medical Case Reports Journal, 2018:11 59-64.  \n\nTo the best of USRM management's knowledge, this is the first result in the world published using stromal vascular fraction (SVF) and autologous stem cells in the successful treatment of psoriasis.\n\n\"This is a breakthrough for the more than 7 million Americans suffering from psoriasis, and is another example of how a patient's own stem cells offer healing modalities for autoimmune conditions,\" said Dr. Comella.  \"Although we require additional studies to further develop more extensive protocol in treating patients with this condition, this is a benchmark indicating there is significant reason to believe the use of autologous stem cells is beneficial in combating this disease.\"\n\nStromal vascular fraction (SVF) is a mixture of adipose-derived stem cells/mesenchymal stem cells, endothelial/progenitors, pericytes, fibroblasts, and other cells) obtained from a patient's own fat tissue. Approximately 60 mL was collected under local anesthesia via a mini-lipoaspirate procedure, which was then separated from the adipocytes via centrifugation after utilizing USRM's AdipocellTM kit to apply enzym...